FORMULARY WATCH

DRUG PRICING

TODAY'S HEADLINES

Turing reverses decision on 5,000% drug price hike

By Christine Blank
Turing Pharmaceuticals on Tuesday reversed its very unpopular decision to raise the price of a 62-year-old drug, Daraprim (pyrimethamine), for toxoplasmosis infections, 5,000%. Cost details

HHS, drugmaker partner on Ebola drug

by Christine Blank
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) and Regeneron Pharmaceuticals in Tarrytown, New York, are partnering to develop a novel Ebola virus treatment. Development costs

CONTINUING EDUCATION

MTM essentials for allergic rhinitis management
Session code: 15DT34-XVK37

This month's CE activity is part of the CPE series, "Medication Therapy Management for the Patient with Respiratory Disease." From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to discuss the pathophysiology and clinical presentation of allergic rhinitis and review nonpharmacologic and pharmacologic treatments for the symptoms of allergic rhinitis.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 15DT34-XVK37.

Copy the session code — 15DT34-XVK37 — before logging into the Online CE Center. When the page for the Online CE Center opens, paste the session code into the appropriate field, under your NABP ID.

FDA increases warning on diabetes medication

by Christine Blank
FDA has strengthened its warning for the type 2 diabetes drug canagliflozin related to the increased risk of bone fractures, and added new information about decreased bone mineral density. Read more

September 25, 2015